Clinical Trial Update: Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating hydroxychloroquine to prevent COVID-19 in healthcare workers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Corona Virus Infection | Phase 3 | Status: WITHDRAWN